BioCryst Pharmaceuticals
| Use attributes for filter ! | |
| Stock price | BCRX |
|---|---|
| Disclaimer | |
| Headquarters | Durham |
| North Carolina | |
| United States | |
| Ceo | Jon P. Stonehouse |
| Number of employees | 37 (2013) |
| CFO | Thomas R Staab II |
| Date of Reg. | |
| Date of Upd. | |
| ID | 761943 |
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina. The company focuses on orphan & autoimmune diseases, and antivirals. The company's most advanced drug candidate is the antiviral Peramivir, which is approved in Japan, Korea and China.
